|
US4443421A
(en)
|
1982-03-16 |
1984-04-17 |
Occidental Chemical Corporation |
Process for removing particulate impurities from aqueous phosphoric acid
|
|
DE3475880D1
(en)
|
1984-08-27 |
1989-02-09 |
Toray Industries |
Solid-liquid separating apparatus
|
|
US5000850A
(en)
|
1986-09-10 |
1991-03-19 |
Engelhard Corporation |
Apparatus for dewatering an aqueous clay suspension
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US7357927B2
(en)
|
1996-03-12 |
2008-04-15 |
Human Genome Sciences, Inc. |
Death domain containing receptors
|
|
AU5052899A
(en)
*
|
1998-07-25 |
2000-02-21 |
Astrazeneca Ab |
Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases
|
|
JP2004194534A
(ja)
|
2002-12-17 |
2004-07-15 |
Sumitomo Pharmaceut Co Ltd |
炎症性腸疾患疾患マーカーおよびその利用
|
|
ES2367566T3
(es)
*
|
2003-10-06 |
2011-11-04 |
Novartis Ag |
Uso de polimorfismos genéticos que se asocian con la eficacia del tratamiento de una enfermedad inflamatoria.
|
|
EP1815021A2
(en)
|
2004-11-03 |
2007-08-08 |
Almac Diagnostics Limited |
Transcriptome microarray technology and methods of using the same
|
|
KR101443050B1
(ko)
|
2005-05-06 |
2014-09-22 |
지모제넥틱스, 인코포레이티드 |
Ｉｌ-31 단클론성 항체 및 사용법
|
|
US20090317388A1
(en)
|
2005-05-25 |
2009-12-24 |
Linda Burkly |
Tl1a in treatment of disease
|
|
EP1963534A2
(en)
*
|
2005-12-19 |
2008-09-03 |
Genizon Biosciences Inc. |
Genemap of the human gene associated with crohn's disease
|
|
WO2008073303A2
(en)
|
2006-12-07 |
2008-06-19 |
Switchgear Genomics |
Transcriptional regulatory elements of biological pathways, tools, and methods
|
|
US20110217310A1
(en)
|
2007-01-10 |
2011-09-08 |
Siegel Richard M |
Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology
|
|
WO2008100913A2
(en)
*
|
2007-02-12 |
2008-08-21 |
The Johns Hopkins University |
Early detection and prognosis of colon cancers
|
|
US20100190162A1
(en)
|
2007-02-26 |
2010-07-29 |
Cedars-Sinai Medical Center |
Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
|
|
WO2008106579A2
(en)
|
2007-02-28 |
2008-09-04 |
Cedars-Sinai Medical Center |
The role of il-12, il-23 and il-17 receptors in inflammatory bowel disease
|
|
US20150376707A1
(en)
*
|
2007-05-18 |
2015-12-31 |
Cedars-Sinai Medical Center |
Methods of diagnosing and treating inflammatory bowel disease
|
|
WO2011088380A1
(en)
*
|
2010-01-15 |
2011-07-21 |
Cedars-Sinai Medical Center |
Methods of using fut2 genetic variants to diagnose crohn's disease
|
|
US8118175B2
(en)
|
2007-07-18 |
2012-02-21 |
Siemens Industry, Inc. |
Venting device for a disc filter
|
|
WO2009039244A2
(en)
*
|
2007-09-18 |
2009-03-26 |
Genizon Biosciences Inc. |
Genemap of the human genes associated with crohn's disease
|
|
US20100240043A1
(en)
|
2007-10-19 |
2010-09-23 |
Cedars-Sinai Medical Center |
Methods of using genetic variants to diagnose and predict inflammatory bowel disease
|
|
UA104132C2
(en)
|
2007-11-13 |
2014-01-10 |
Тева Биофармасьютикалз Юесей, Инк. |
Humanized antibodies against tl1a
|
|
CA2735578C
(en)
*
|
2008-08-12 |
2018-10-23 |
Zinfandel Pharmaceuticals, Inc. |
Method of identifying risk factors for alzheimer's disease comprising tomm40 gene variants
|
|
DK2329259T3
(en)
|
2008-08-29 |
2016-05-09 |
Janssen Biotech Inc |
MARKERS AND PROCEDURES FOR ASSESSING AND TREATING ULCERATIVE COLITIS AND RELATED DISEASES USING A 20-GEN PANEL
|
|
JP2010088432A
(ja)
|
2008-09-09 |
2010-04-22 |
Kansetsu Saisei Kenkyusho:Kk |
Ｔｎｆ阻害薬治療による有効性・副作用発現に関する多型、およびその利用
|
|
US20110229471A1
(en)
|
2008-11-26 |
2011-09-22 |
Cedars-Sinai Medical Center |
Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
|
|
US9580752B2
(en)
*
|
2008-12-24 |
2017-02-28 |
Cedars-Sinai Medical Center |
Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
|
|
WO2010120814A1
(en)
|
2009-04-14 |
2010-10-21 |
Prometheus Laboratories Inc. |
Inflammatory bowel disease prognostics
|
|
JP2013528389A
(ja)
*
|
2010-06-04 |
2013-07-11 |
ネステク ソシエテ アノニム |
炎症性腸疾患の診断を改善させる方法
|
|
US8766034B2
(en)
|
2010-09-22 |
2014-07-01 |
Cedars-Sinai Medical Center |
TL1A model of inflammation fibrosis and autoimmunity
|
|
CA2817256A1
(en)
|
2010-11-12 |
2012-05-18 |
The General Hospital Corporation |
Polycomb-associated non-coding rnas
|
|
US9902996B2
(en)
|
2011-02-11 |
2018-02-27 |
Cedars-Sinai Medical Center |
Methods of predicting the need for surgery in crohn's disease
|
|
AU2012253422B2
(en)
|
2011-05-10 |
2015-08-13 |
Société des Produits Nestlé S.A. |
Methods of disease activity profiling for personalized therapy management
|
|
WO2012156515A1
(en)
|
2011-05-18 |
2012-11-22 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Molecular analysis of acute myeloid leukemia
|
|
WO2012161856A1
(en)
|
2011-05-20 |
2012-11-29 |
Government Of The United States, As Represented By The Secretary, Department Of Health And Human Services |
Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof
|
|
CN103732623B
(zh)
|
2011-06-03 |
2017-09-29 |
佐马技术有限公司 |
对TGF‑β具有特异性的抗体
|
|
JP2015502740A
(ja)
*
|
2011-10-21 |
2015-01-29 |
ネステク ソシエテ アノニム |
炎症性腸疾患の診断を改善するための方法
|
|
WO2013117751A2
(en)
*
|
2012-02-10 |
2013-08-15 |
Novo Nordisk A/S |
Methods related to treatment of inflammatory diseases and disorders
|
|
KR20230109779A
(ko)
|
2013-03-27 |
2023-07-20 |
세다르스-신나이 메디칼 센터 |
Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한섬유증 및 염증의 완화 및 반전
|
|
ES2894963T3
(es)
*
|
2013-05-17 |
2022-02-16 |
Cedars Sinai Medical Center |
Variantes de TNFSF15 y DcR3 asociadas con la enfermedad de Crohn
|
|
RU2683781C2
(ru)
|
2013-10-09 |
2019-04-02 |
Седарс-Синаи Медикал Сентер |
Диагностика и лечение синдрома раздраженного кишечника и воспалительного заболевания кишечника
|
|
EP3736344A1
(en)
*
|
2014-03-13 |
2020-11-11 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
|
US20180305689A1
(en)
|
2015-04-22 |
2018-10-25 |
Mina Therapeutics Limited |
Sarna compositions and methods of use
|
|
EP3419932A4
(en)
|
2016-02-26 |
2019-09-04 |
Nanotech Energy, Inc. |
METHODS, DEVICES AND SYSTEMS FOR PROCESSING CARBON-CONTAINING COMPOSITIONS
|
|
EP3458466B1
(en)
|
2016-05-20 |
2024-08-07 |
Cedars-Sinai Medical Center |
Diagnosis of inflammatory bowel disease based on genes
|
|
WO2018022982A1
(en)
|
2016-07-29 |
2018-02-01 |
Trustees Of Boston University |
Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development
|
|
KR20190082815A
(ko)
|
2016-10-26 |
2019-07-10 |
세다르스-신나이 메디칼 센터 |
중화 항-tl1a 단일 클론 항체
|
|
WO2018204764A1
(en)
|
2017-05-05 |
2018-11-08 |
Camp4 Therapeutics Corporation |
Identification and targeted modulation of gene signaling networks
|
|
WO2020121618A1
(ja)
|
2018-12-14 |
2020-06-18 |
株式会社フジクラ |
フェルール、ファイバ付きフェルール及びファイバ付きフェルールの製造方法
|